An interventional study of Starry-Sky Projection and Conventional Lighting in Congenital Heart Disease (CHD) and Postoperative Sleep, sponsored by Shanghai Jiao Tong University School of Medicine. Not yet recruiting at 1 site in China. Open to participants aged 6 Months to 6 Years. Per ClinicalTrials.gov, last updated 2026-10-30.
Sponsored by Shanghai Jiao Tong University School of Medicine · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 79 studies in Heart Defects, Congenital with a site in China — 27 open to participants now, 30 under way, none of them phase 3. Heart Defects, Congenital · China.
Among the 79 studies in Heart Defects, Congenital with a site in China, this one is the 20th largest by planned enrollment of the 41 interventional ones that give a count, is one of 8 that started in 2026, is one of 31 with no phase, reaches primary completion later than 17 of the 29 other live ones, and was the 79th registered.
992 studies on the registry are indexed under Heart Defects, Congenital; 252 are open to participants now.
Browse Heart Defects, Congenital studies →27 of the 79 studies in Heart Defects, Congenital with a site in China are open now. Recruiting first, the newest first:
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine · Sites in China
Ages up to 18
Children's Hospital of Fudan University · Sites in China
Ages 0 mo–6 mo
Yan Fuxia · Sites in China
Ages 1 days–3 yrs
Yan Fuxia · Sites in China
Ages 6–12
China National Center for Cardiovascular Diseases · Sites in China
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 156 Heart Defects, Congenital studies recruiting now, 69 (44%) set no upper age limit and 79 (51%) stop at 75 or younger; 112 take children under 18; 25 take healthy volunteers.
This study: 6 Months to 6 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
79 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 3 · Phase 3 5 · Phase 4 2
First in 2000; this study’s year is marked. 8 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 172 is above the median of 60 across 508 interventional studies indexed under Heart Defects, Congenital.
Median enrollment 160 across the 41 interventional studies, 1,554 across the 38 observational. Of the 30 that completed or were terminated, 3 (10%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 79 have an industry lead sponsor. The 10 most frequent:
Shanghai Jiao Tong University School of Medicine is the lead sponsor of 374 studies on the registry; 110 are open to participants now.
Shanghai Jiao Tong University School of Medicine has 4 studies filed under Heart Defects, Congenital — fewer than ten, so there is no comparison to draw.
6 of the studies in Heart Defects, Congenital with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06747546Children's Hospital of Fudan UniversityResearch on Circulation Management Strategy Based on Oxygen Metabolism Balance After CHD Surgery | 2026-12-31 |
| NCT06542120Xinhua Hospital, Shanghai Jiao Tong University School of MedicineResearch on Body Voice AI Recognition System for Children's Health Management | 2026-12-31 |
| NCT07115108Children's Hospital of Fudan UniversityEffectiveness of High-Energy Density Enteral Nutrition for Enhancing Physical Growth and Cognitive Brain Development in Infants With Congenital Heart Disease | 2026-12-31 |
| NCT07854145Shanghai Jiao Tong University School of MedicineStarry-Sky Projection and Maternal Voice for Sleep After Pediatric Cardiac Surgery | 2027-03-31 |
| NCT07375602Xinhua Hospital, Shanghai Jiao Tong University School of MedicineA Multimodal AI Prediction Model for Complications After Transcatheter Closure of Perimembranous VSD in Children | 2027-06-01 |
Add all 6 to your calendar (.ics) → With an account.
Among the 79 studies in Heart Defects, Congenital with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to determine whether a starry-sky projection affects sleep during the early period after cardiac surgery in young children. The main question it aims to answer is:
Children aged 6 months to 6 years will be randomly assigned to one of four combinations of visual and sound conditions. They will:
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Behavioral: Starry-Sky Projection · Behavioral: Maternal Voice
Behavioral: Starry-Sky Projection · Behavioral: Unfamiliar Female Voice
Other: Conventional Lighting · Behavioral: Maternal Voice
Other: Conventional Lighting · Behavioral: Unfamiliar Female Voice
A starry-sky projector will display gently moving, diffuse star-like points on the ceiling, avoiding direct light exposure to the child's eyes. Settings will remain constant, without rapid movement, frequent colour changes, or visible flicker. Built-in audio will be disabled. Sessions will last 30 minutes before anticipated sleep onset on postoperative nights 0-2.
Participants will remain under routine nocturnal lighting in the CICU or general ward without additional projection.
A personalised recording from the child's mother containing the child's name, reassuring and sleep-related phrases, and a familiar lullaby or gentle melody will be played for 30 minutes before anticipated sleep onset. The recording will be played using a speaker positioned approximately 20 cm from the child's ear, with sound intensity maintained at 45-50 dB.
A standardized recording by an unfamiliar adult woman who is not involved in the child's clinical care will be played for 30 minutes before anticipated sleep onset. The recording will contain generic reassuring and sleep-related phrases and a gentle lullaby or nursery rhyme. Playback duration, speaker placement, and sound intensity will be identical to the maternal voice condition.
Sleep Efficiency
Sleep efficiency is defined as the percentage of total sleep time (TST) relative to time in bed (TIB) during the sleep-related nocturnal interval. TIB refers to the interval from the start of an attempt to sleep until the end of the nocturnal sleep opportunity and includes sleep onset latency and intervening wakefulness. Sleep efficiency will be assessed using a contactless ballistocardiography (BCG)-based sleep monitoring mat during postoperative nights 0-2. The mean sleep efficiency across the three postoperative nights will be used as the primary outcome measure. Higher values indicate better sleep efficiency.
Time frame: Postoperative nights 0, 1, and 2
Total Sleep Time
Total sleep time during the nocturnal monitoring period, measured using a contactless sleep monitoring mat.
Time frame: Postoperative nights 0, 1, and 2
Sleep-Onset Latency
Time from the beginning of the nocturnal sleep monitoring period to sleep onset, measured using a contactless sleep monitoring mat.
Time frame: Postoperative nights 0, 1, and 2
Wake After Sleep Onset
Total duration of wakefulness occurring after sleep onset during the nocturnal monitoring period, measured using a contactless sleep monitoring mat.
Time frame: Postoperative nights 0, 1, and 2
Sleep Fragmentation Index
Sleep fragmentation index derived from the contactless sleep monitoring mat, reflecting the degree of sleep disruption during the nocturnal monitoring period.
Time frame: Postoperative nights 0, 1, and 2
Sleep-Stage Distribution
Estimated distribution of sleep stages during the nocturnal monitoring period, expressed as the proportion of total sleep time and measured using a contactless sleep monitoring mat.
Time frame: Postoperative nights 0, 1, and 2
Incidence of Postoperative Delirium
Postoperative delirium will be assessed using the Cornell Assessment of Pediatric Delirium (CAPD). A total CAPD score ≥9 will indicate a positive delirium screen. Assessments will be performed every 12 hours.
Time frame: Postoperative night 0 through postoperative day 2
Richmond Agitation-Sedation Scale Score
Sedation and agitation will be assessed using the Richmond Agitation-Sedation Scale (RASS). Scores range from -5 to +4, with lower scores indicating deeper sedation and higher scores indicating greater agitation. Assessments will be performed every 4 hours.
Time frame: Postoperative night 0 through postoperative day 2
Pain Score
Postoperative pain will be assessed using the Face, Legs, Activity, Cry, Consolability (FLACC) scale. Scores range from 0 to 10, with higher scores indicating greater pain severity. Assessments will be performed every 4 hours.
Time frame: Postoperative night 0 through postoperative day 2
Postoperative Sedative Exposure
Administration of dexmedetomidine and other sedative medications will be recorded to characterize postoperative sedative exposure.
Time frame: Postoperative day 0 through postoperative day 2
Postoperative Analgesic Exposure
Administration of sufentanil and other analgesic medications will be recorded to characterize postoperative analgesic exposure.
Time frame: Postoperative day 0 through postoperative day 2
Postoperative Vasoactive Medication Exposure
Administration of dopamine and other vasoactive medications will be recorded to characterize postoperative vasoactive medication exposure.
Time frame: Postoperative day 0 through postoperative day 2
Heart Rate Variability
Heart rate variability will be continuously measured using the 5S Sleep Tracking Mat as an objective indicator of autonomic regulation.
Time frame: Postoperative nights 0, 1, and 2
CICU Length of Stay
Cardiac intensive care unit (CICU) length of stay will be calculated from postoperative CICU admission to CICU discharge.
Time frame: Measured in days admitted to the CICU, an average of 2 days
Total Hospital Length of Stay
Total hospital length of stay will be calculated as the number of days from hospital admission to hospital discharge.
Time frame: Measured in days admitted to the hospital, an average of 10 days.
Parental satisfaction
Parental satisfaction with the child's overall hospital care will be assessed using a 100-mm visual analogue scale (VAS), ranging from 0 mm ("very dissatisfied") to 100 mm ("very satisfied"). Higher scores indicate greater satisfaction.
Time frame: On the day of discharge, an average of 10 days
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Nov 2026; primary completion for Mar 2027, 4 months later.
Of 208 non-industry interventional studies with no phase under Heart Defects, Congenital, half reached primary completion within 34 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 53. This study's planned 4 months is below that.
Counting every sponsor, half of 226 studies reached it within 34 months; a quarter within 17 and three quarters within 57.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 30, 2026: start Oct 2026 → Nov 2026, primary completion Dec 2026 → Mar 2027 and completion Dec 2026 → Mar 2027.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Shanghai Jiao Tong University School of Medicine →